semaglutide shortage end Federal judge upholds FDA's removal of Ozempic, Wegovy from drug list The Ozempic Shortage Is Over

Many people are searching for ways to lose weight and feel healthier

Enteroendocrine L-cell derived peptide hormones, notably glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2), have become important targets in the treatment of type 2 diabetes, obesity and intestinal diseases

Individual timelines vary based on starting dose, body composition, and genetic factors that influence GLP-1 receptor sensitivity

A new approach to weight loss

The epidemic rise in the prevalence of obesity has metabolic consequences and is paralleled by an increased occurrence of other diseases, such as diabetes, cancer and cardiovascular complications

PlexusDx explains the risks, clinical evidence, and why a single-agent GLP-1 approach may be safer and more effective for your goals